Retained Earnings (Accumulated Deficit) of Intra-Cellular Therapies, Inc. from 31 Dec 2012 to 31 Dec 2024

Taxonomy & unit
us-gaap: USD
Description
The cumulative amount of the reporting entity's undistributed earnings or deficit.
Summary
Intra-Cellular Therapies, Inc. quarterly Retained Earnings (Accumulated Deficit) in USD history and change rate from 31 Dec 2012 to 31 Dec 2024.
  • Intra-Cellular Therapies, Inc. Retained Earnings (Accumulated Deficit) for the quarter ending 31 Dec 2024 was $1,691,836,000, a 4.6% decline year-over-year.
Source SEC data
View on sec.gov
Retained Earnings (Accumulated Deficit), Quarterly (USD)
Retained Earnings (Accumulated Deficit), YoY Quarterly Change (%)

Intra-Cellular Therapies, Inc. Quarterly Retained Earnings (Accumulated Deficit) (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q4 2024 $1,691,836,000 -$74,676,000 -4.6% 31 Dec 2024 10-K 21 Feb 2025 2024 FY
Q3 2024 $1,674,951,000 -$86,370,000 -5.4% 30 Sep 2024 10-Q 30 Oct 2024 2024 Q3
Q2 2024 $1,648,627,000 -$84,304,000 -5.4% 30 Jun 2024 10-Q 07 Aug 2024 2024 Q2
Q1 2024 $1,632,407,000 -$110,868,000 -7.3% 31 Mar 2024 10-Q 07 May 2024 2024 Q1
Q4 2023 $1,617,160,000 -$139,674,000 -9.5% 31 Dec 2023 10-K 21 Feb 2025 2024 FY
Q3 2023 $1,588,581,000 -$155,121,000 -11% 30 Sep 2023 10-Q 02 Nov 2023 2023 Q3
Q2 2023 $1,564,323,000 -$184,371,000 -13% 30 Jun 2023 10-Q 03 Aug 2023 2023 Q2
Q1 2023 $1,521,539,000 -$228,190,000 -18% 31 Mar 2023 10-Q 04 May 2023 2023 Q1
Q4 2022 $1,477,486,000 -$256,256,000 -21% 31 Dec 2022 10-K 22 Feb 2024 2023 FY
Q3 2022 $1,433,460,000 -$297,964,239 -26% 30 Sep 2022 10-Q 03 Nov 2022 2022 Q3
Q2 2022 $1,379,952,000 -$321,364,243 -30% 30 Jun 2022 10-Q 09 Aug 2022 2022 Q2
Q1 2022 $1,293,349,000 -$303,505,025 -31% 31 Mar 2022 10-Q 10 May 2022 2022 Q1
Q4 2021 $1,221,230,000 -$284,125,968 -30% 31 Dec 2021 10-K 01 Mar 2023 2022 FY
Q3 2021 $1,135,495,761 -$259,090,907 -30% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 $1,058,587,757 -$237,366,528 -29% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 $989,843,975 -$232,335,004 -31% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 $937,104,032 -$227,005,663 -32% 31 Dec 2020 10-K 01 Mar 2022 2021 FY
Q3 2020 $876,404,854 -$206,889,336 -31% 30 Sep 2020 10-Q 09 Nov 2020 2020 Q3
Q2 2020 $821,221,229 -$186,568,110 -29% 30 Jun 2020 10-Q 10 Aug 2020 2020 Q2
Q1 2020 $757,508,971 -$160,297,017 -27% 31 Mar 2020 10-Q 07 May 2020 2020 Q1
Q4 2019 $710,098,369 -$147,722,178 -26% 31 Dec 2019 10-K 25 Feb 2021 2020 FY
Q3 2019 $669,515,518 -$147,887,363 -28% 30 Sep 2019 10-Q 05 Nov 2019 2019 Q3
Q2 2019 $634,653,119 -$154,547,878 -32% 30 Jun 2019 10-Q 07 Aug 2019 2019 Q2
Q1 2019 $597,211,954 -$154,483,096 -35% 31 Mar 2019 10-Q 08 May 2019 2019 Q1
Q4 2018 $562,376,191 -$155,127,411 -38% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 $521,628,155 -$144,588,087 -38% 30 Sep 2018 10-Q 07 Nov 2018 2018 Q3
Q2 2018 $480,105,241 -$125,935,589 -36% 30 Jun 2018 10-Q 02 Aug 2018 2018 Q2
Q1 2018 $442,728,858 -$106,319,910 -32% 31 Mar 2018 10-Q 03 May 2018 2018 Q1
Q4 2017 $407,248,780 -$97,773,414 -32% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q3 2017 $377,040,068 -$95,049,741 -34% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 $354,169,652 -$102,444,652 -41% 30 Jun 2017 10-Q 09 Aug 2017 2017 Q2
Q1 2017 $336,408,948 -$115,518,401 -52% 31 Mar 2017 10-Q 10 May 2017 2017 Q1
Q4 2016 $309,475,366 -$116,426,268 -60% 31 Dec 2016 10-K 01 Mar 2018 2017 FY
Q3 2016 $281,990,327 -$117,775,745 -72% 30 Sep 2016 10-Q 09 Nov 2016 2016 Q3
Q2 2016 $251,725,000 -$119,670,901 -91% 30 Jun 2016 10-Q 04 Aug 2016 2016 Q2
Q1 2016 $220,890,547 -$110,347,766 -100% 31 Mar 2016 10-Q 28 Apr 2016 2016 Q1
Q4 2015 $193,049,098 -$104,793,141 -119% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q3 2015 $164,214,582 -$91,157,755 -125% 30 Sep 2015 10-Q 05 Nov 2015 2015 Q3
Q2 2015 $132,054,099 -$65,412,779 -98% 30 Jun 2015 10-Q 05 Aug 2015 2015 Q2
Q1 2015 $110,542,781 -$48,435,000 -78% 31 Mar 2015 10-Q 30 Apr 2015 2015 Q1
Q4 2014 $88,255,957 -$30,691,460 -53% 31 Dec 2014 10-K 25 Feb 2016 2015 FY
Q3 2014 $73,056,827 -$23,533,140 -48% 30 Sep 2014 10-Q 03 Nov 2014 2014 Q3
Q2 2014 $66,641,320 30 Jun 2014 10-Q 12 Aug 2014 2014 Q2
Q1 2014 $62,107,781 31 Mar 2014 10-Q 05 May 2014 2014 Q1
Q4 2013 $57,564,497 -$26,868,198 -88% 31 Dec 2013 10-K 12 Mar 2015 2014 FY
Q3 2013 $49,523,687 30 Sep 2013 10-Q 05 Nov 2013 2013 Q3
Q4 2012 $30,696,299 31 Dec 2012 10-K 25 Mar 2014 2013 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.